Prosper AI’s platform automates what the company and its investors call "the voice-heavy work for clinic operations end-to-end" . The core capabilities include:
The stated goal goes beyond basic automation: Prosper AI aims to fully replace the traditional phone-call-based model of healthcare administration with a unified, AI-driven system that can manage scheduling, financial clearance, and reimbursement without human intervention at each step .
The $30 million Series A was led by a16z, whose partners Jay Rughani and Jane Rhee wrote publicly about the investment thesis: "Fixing healthcare’s phone call crisis is how you rebuild the administrative core of healthcare globally" . Additional participants in the round included Base10 Partners, while existing investors Emergence Capital, Y Combinator, and Company Ventures also participated
. The company has now raised a total of $36.6 million across all rounds
.
According to the official announcement and corroborating coverage, Prosper AI experienced rapid commercial acceleration in the period between its prior funding and the June 2026 Series A . Key reported metrics include:
While the available sources do not name specific customer deployments, the company describes its client base as including healthcare organizations and healthcare technology partners .
The investment arrives at a time when health systems face intense pressure to reduce administrative costs and address staffing shortages . Prosper AI’s pitch is that its platform doesn't just add a chatbot to existing systems — it rebuilds the administrative core of clinic operations around AI, potentially cutting costs and wait times while improving financial clearance accuracy.